Janney Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Sep 17, 2021
- Accession no.
- 0000899243-21-036429
- Filed
- Sep 17, 2021, 4:47 PM ET
- Trade date
- Sep 17, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $2.50M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Janney DanielCIK 0001198325 | 10% Owner |
| Hudson Peter ACIK 0001674884 | 10% Owner |
| Alta Partners NextGen Fund II, L.P.CIK 0001768658 | 10% Owner |
| Alta Partners NextGen Fund II Management, LLCCIK 0001881002 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | CConversionAcquired | +3,811,117 | –F1 | – | 3,924,046 | Indirect | Duplicate filing |
| Sep 17, 2021 | Common Stock | PPurchaseAcquired | +156,250 | $16.00 | +$2,500,000 | 4,080,296 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | Common Stock | CConversionDisposed | −3,148,365 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
| Sep 17, 2021 | Common Stock | CConversionDisposed | −662,752 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date. As a result of the Issuer's initial public offering, the reporting persons are no longer 10% owners of the Issuer's common stock and are, therefore, no longer subject to Section 16 in connection with their transactions in the equity securities of the Issuer.
Referenced by the price of 1 transaction in Table I.